Results of a long-term follow-up in the treatment of endometriosis with leuprorelinacetate depot;ERGEBNISSE EINES LANGZEIT FOLLOW-UP BEI DER BEHANDLUNG DER ENDOMETRIOSE MIT DEM GNRH-AGONISTEN LEUPRORELINACETAT-DEPOT

Zentralblatt fur Gynakologie

Volumn 118, Issue 5, 1996, Pages 283-290

  Regidor, P A ^a   Schindler, A E ^a   Buhler K ^a   Gerhard, I ^b   Kimmig, R ^c   Meinen, K ^d   Hoffmann, G ^e   Lubben G ^f   Kienle, E ^f  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Frauenkl St Lukas Klin Solingen   (Germany)

^e Frauenkl St Josef Hospitals W

^f Takeda Pharma GmbH   (Germany)

Author keywords

endometriosis; follow up; GnRH agonists; leuprorelinacetate depot; recurrence of endometriosis

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN;

ADULT; ARTICLE; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; PREGNANCY; QUALITY OF LIFE; RECURRENT DISEASE;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; DELAYED-ACTION PREPARATIONS; ENDOMETRIOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFERTILITY, FEMALE; INJECTIONS, SUBCUTANEOUS; LEUPROLIDE; PREGNANCY; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME;

EID: 0029971947     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Adamson GD, Frison L, Lamb EJ: Endometriosis: studies of a method for the design of a surgical staging system. Fertil Steril 38 (1982) 659-666
2. Andrews WC. Larsen GD: Endometriosis: Treatment with hormonal pseudopresnancy and/or operation. Am J Obst Gynecol (1974) 643-651
3. Bühler K: Therapieregime zur Behandlung der Endometriose: Einsatz in der tätlichen Praxis. Fertilität 11 (1995) 1-4 (Im Druck)
4. Bühler K, Schindler AE: Long-term follow-up of patients treated for endometriosis with LHRH Analogue Buserelin. In: LHRH analogues in Gynaecology. Hrsg.: Brosens I. Jacobs HS. Runnebaum B. Carnforth: Parthenon Publishing 1990
5. Busacca M, Candiani M, Carlini L. Gonfiantini C. Vignali M: Clinical aspects of endometriosis: retrospective analysis of a personal study. Abstract P31, 3rd World Congress on Endometriosis, Brussels 1992
6. Cooke JD, Thomas EJ: The Medical Treatment of Mild Endometriosis. Acta Obstet Gynecol Scand 150 (1989) Suppl. 27-30
7. Dizerga GS, Barber DL, Hodgen GD: Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance and Suppression. Fertil Steril 33 (1980) 649-653
8. Dlugi AM: Lupron Depot (Leuprolide Acetate for Depot Suspension) in the Treatment of Endometriosis: A Randomized, Placebo-Controlled, Dobuble-Blind Study. Fertil Steril 54 (1990) 419-427
9. Gerhard I, Monga B. Runnebaum B: Endometriose und Umwelt. Der Frauenarzt 36 (1995) 215-218
10. Guzick DS, Bross DS, Rock JA: Assessing the efficacy of the American Fertility Society Classification of endometriosis: application of a dose-response methodology. Fertil Steril 38 (1982) 171-176
11. Hoshiai H: Laparoscopic evaluation of the onset and progression of endometriosis. Am J Obst Gynecol 169 (1993) 714-719
12. Hughes EG, Fedorkow DM, Collins JA: A quantitative overview of controlled trials in endometrioses associated infertillity. Fertil Steril 59 (1993) 963-970
13. Jürgensen A, Volkow N, Mettler L, Parwaresch R: Proliferationsaktivität des Endometriums während des Menstruationszyklus bei Endometriose und Sterilität. Fertilität 10 (1994) 98-104
14. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E. Cornillie FJ: Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 55 (1991) 759-765
15. Mahmood AT, Templeton A: The impact of treatment on the natural history of endometriosis. Hum Reprod 5 (1990) 965-970
16. Malinak LR, Hofstadter A, Del Junco DJ: Recurrence of endometriosis after combined GnRH-agonist surgical therapy. Abstract P20, 3rd World Congress on Endometriosis, Brussels 1992
17. Marcus SF, Edwards RG: High rates of pregnancy after long-term down-regulation of women with severe endometriosis. Am J Obstet Gynecol 171 (1994) 812-817
18. Meldrum D, Wisot A, Hamilton F, Gutlay-Yeo AL, Marr B, Huynh D: Artificial agonadism and hormone replacement for oocyte donation. Fertil Steril 52 (1989) 509-511
19. Mettler L: Kombinierte endoskopische und hormonelle Therapie der Endometriose. Speculum 11 (1993) 10-15
20. Miller JD: Leuprolide acetate for treatment of endometriosis. Prog Clin Biol Res 323 (1990) 337-341
21. Moghissi KS: Mangement of endometriosis with oral medroxyprogesterone acetate. Obstet Gynecol 47 (1976) 265-267
22. Nakamura H, Oosawa M, Kondou J, Inagaki S, Shibata H, Narita O, Suganuma N, Tomoda Y: Menotropin Stimulation after Prolonged Gonadotropin Releasing Hormone Agoinst Pretreatment for in Vitro Fertilization in Patients with Endometriosis. J Assit Reprod Genet 9 (1992) 113-117
23. Redwine DB: Age-related evolution in color appearance of endometriosis. Fertil Steril 48 (1987) 1062-1063
24. Schindler AE, Bühler K, Gerhard I, Wiedemann R, Kimmig R, Schüssler B, Kranzfelder D, Mall-Häfeli M, Meinen K, Macaralla D, Hoffmann G, Kienle E: Behandlung der Endometriose mit dem GnRH-Agonisten Leuprorelitiacetat Depot (Enantone®-Gyn MonatsDepot): Eine multizentrische Studie. Zentralbl Gynakol 116 (1994) 679-686
25. Schindler AE: Endometriose und Fertilitätsstörungen. Der Frauenarzt 2 (1995) 211-214
26. Schindler AE, Martini L: GnRH analogues in obstetrics and gynecology: Focus on leuprorelinacetate. Clinical Therapeutics 14 (1992) Suppl. A 1-130
27. Semm K: Differentialdiagnostik der Endometriose. Endometriose 3 (1985) 21-37
28. Schweppe KW: Die Bedeutung der Diagnostik und Therapie der Endometriose zur Prophylaxe der weiblichen Sterilität. Der Frauenarzt 6 (1994) 699-706
29. Schweppe KW: Eine progrediente und invasive Erkrankung: Endometriose. Gynecol 8 (1993) 173-174
30. Schweppe KW: Endometriose: Medikamentöse und operative Behandlung. Arzneimitteltherapie 12 (1994) 342-348
31. Schweppe KW: Individuelle Endometriosebehandlung. Endometriose 9 (1994) Sonderveröffentlichung
32. Schweppe KW: Therapieerfolge und Rezidivrate nach Endometriose-Behandlung mit Danazol. Endometriose 5 (1987) 4-11
33. Surrey ES, Judd HL: Reduction of Vasomotor Symptoms and Bone Mineral Density Loss with Combined Norethindrone and Long-Acting Gonadotropin-Releasing Hormone Agonist Therapy of Symptomatic Endometriosis: A Prospective Randomized Trial. J Clin Endocrinol Metab 75 (1992) 558-562
34. Thaele M, Bühler KV, Seebacher HB: Differentialdiagnostik in der zytologischen Beurteilung der Endometriose. Der Frauenarzt 36 (1995) 340-343
35. Thomas EJ, Cooke JD: Impact of gestrinone on the course of asymptomatic endometriosis. B M J 294 (1987) 272-274
36. Waller KG, Shaw RW: Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 59 (1993) 511-515
37. Wheeler JM, Knittle JD, Miller JD: Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. efficacy results. Am J Obstet Gynecol 167 (1992) 1367-1371
38. Yovich J: Endometriosis and assisted reproduction. Abstract 0369, FIGO. Singapur 1991